Limits...
A comparison between tube surgery, ND:YAG laser and diode laser cyclophotocoagulation in the management of refractory glaucoma.

Bloom PA, Clement CI, King A, Noureddin B, Sharma K, Hitchings RA, Khaw PT - Biomed Res Int (2013)

Bottom Line: Control of IOP was best in patients receiving tube surgery.Cyclodiode and cycloYAG treatments were similarly effective in lowering IOP.Tube surgery was associated with a greater incidence of sight threatening complications.

View Article: PubMed Central - PubMed

Affiliation: Western Eye Hospital, 153-173 Marylebone Road, London NW1 5QH, UK.

ABSTRACT

Purpose: To compare the results of intraocular pressure (IOP) reduction by 3 treatment modalities, (a) glaucoma tube implants, (b) noncontact YAG laser cyclophotocoagulation (cycloYAG), and (c) contact transscleral diode laser cyclophotocoagulation (cyclodiode), in cases of advanced glaucoma refractory to alternative treatments.

Methods: A consecutive group of 45 eyes that received cycloYAG were matched against two control groups of patients who had received tube surgery or cyclodiode, each control group having been derived from a database of patients.

Results: Mean pretreatment IOP improved from 41.3, 38.6, and 32.0 mmHg for the tube, cycloYAG, and cyclodiode groups, respectively, to 16.4, 22.1, and 19.3 mmHg, respectively. Treatment success was achieved in 78%, 69%, and 71% of the tube, cycloYAG, and cyclodiode groups, respectively. Visual acuity deteriorated 2 or more Snellen lines in 16%, 7%, and 9% of the patients in the tube, cycloYAG, and cyclodiode groups, respectively. Complications included retinal detachment, hypotony, and phthisis.

Conclusions: All 3 methods provided acceptable IOP lowering in the short and medium term. Control of IOP was best in patients receiving tube surgery. Cyclodiode and cycloYAG treatments were similarly effective in lowering IOP. Tube surgery was associated with a greater incidence of sight threatening complications.

Show MeSH

Related in: MedlinePlus

Change in Snellen visual acuity following treatment for cycloYAG group.
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC3814063&req=5

fig6: Change in Snellen visual acuity following treatment for cycloYAG group.

Mentions: Figures 5, 6, and 7 show the “raw data” for pretreatment VA and VA at last followup, for each treatment group. The pretreatment VA varied between 6/6 and HM in the tube group and between 6/9 and NPL in both the cycloYAG and cyclodiode group.


A comparison between tube surgery, ND:YAG laser and diode laser cyclophotocoagulation in the management of refractory glaucoma.

Bloom PA, Clement CI, King A, Noureddin B, Sharma K, Hitchings RA, Khaw PT - Biomed Res Int (2013)

Change in Snellen visual acuity following treatment for cycloYAG group.
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC3814063&req=5

fig6: Change in Snellen visual acuity following treatment for cycloYAG group.
Mentions: Figures 5, 6, and 7 show the “raw data” for pretreatment VA and VA at last followup, for each treatment group. The pretreatment VA varied between 6/6 and HM in the tube group and between 6/9 and NPL in both the cycloYAG and cyclodiode group.

Bottom Line: Control of IOP was best in patients receiving tube surgery.Cyclodiode and cycloYAG treatments were similarly effective in lowering IOP.Tube surgery was associated with a greater incidence of sight threatening complications.

View Article: PubMed Central - PubMed

Affiliation: Western Eye Hospital, 153-173 Marylebone Road, London NW1 5QH, UK.

ABSTRACT

Purpose: To compare the results of intraocular pressure (IOP) reduction by 3 treatment modalities, (a) glaucoma tube implants, (b) noncontact YAG laser cyclophotocoagulation (cycloYAG), and (c) contact transscleral diode laser cyclophotocoagulation (cyclodiode), in cases of advanced glaucoma refractory to alternative treatments.

Methods: A consecutive group of 45 eyes that received cycloYAG were matched against two control groups of patients who had received tube surgery or cyclodiode, each control group having been derived from a database of patients.

Results: Mean pretreatment IOP improved from 41.3, 38.6, and 32.0 mmHg for the tube, cycloYAG, and cyclodiode groups, respectively, to 16.4, 22.1, and 19.3 mmHg, respectively. Treatment success was achieved in 78%, 69%, and 71% of the tube, cycloYAG, and cyclodiode groups, respectively. Visual acuity deteriorated 2 or more Snellen lines in 16%, 7%, and 9% of the patients in the tube, cycloYAG, and cyclodiode groups, respectively. Complications included retinal detachment, hypotony, and phthisis.

Conclusions: All 3 methods provided acceptable IOP lowering in the short and medium term. Control of IOP was best in patients receiving tube surgery. Cyclodiode and cycloYAG treatments were similarly effective in lowering IOP. Tube surgery was associated with a greater incidence of sight threatening complications.

Show MeSH
Related in: MedlinePlus